ATAI Life Sciences BV (ATAI) — Long-term Investment Intensity

Latest as of December 2025: 2.8%

ATAI Life Sciences BV (ATAI) has a Long-term Investment Intensity of 2.8% as of December 2025. Long-term investments of $8.73 Million represent 2.8% of total assets of $310.54 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ATAI Life Sciences BV (ATAI) shareholders funds for net asset value and shareholders' equity analysis.

LT Investment Intensity

2.8%
LT Investments / Total Assets

Long-term Investments

$8.73 Million
USD

Total Assets

$310.54 Million
USD

Country

USA
NASDAQ

ATAI Life Sciences BV Long-term Investment Intensity (2019–2025)

This chart shows how ATAI Life Sciences BV's Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the intensity stands at 2.8%, reflecting long-term investments of $8.73 Million against total assets of $310.54 Million USD. Also explore ATAI Life Sciences BV (ATAI) total assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for ATAI Life Sciences BV (2019–2025)

The table below presents the year-by-year Long-term Investment Intensity for ATAI Life Sciences BV from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of ATAI Life Sciences BV.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 2.8% $8.73 Million $310.54 Million ▼ -41.7 pp
2024 44.5% $70.97 Million $159.39 Million ▲ +13.3 pp
2023 31.2% $91.66 Million $293.48 Million ▲ +26.6 pp
2022 4.6% $14.02 Million $305.44 Million ▼ -2.1 pp
2021 6.7% $27.76 Million $414.17 Million ▼ -0.5 pp
2020 7.2% $8.04 Million $111.55 Million ▼ -29.7 pp
2019 36.9% $22.95 Million $62.12 Million
pp = percentage points